Product Information
IBUPROFEN 100 MG/5 ML SUSP is a generic product labeled by Actavis Pharma, Inc., priced at $0.0244 per ML under NDC 00472200216. Its NADAC has been published 411 times since Aug 15, 2018.
Strength
100 mg/5mL
Manufacturer
Actavis Pharma, Inc.NDC
00472200216
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA074978On Market Since
7/16/2018
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 100 MG/5 ML SUSP has been published 411 times since Aug 15, 2018, and over the history we have for it it has declined 33.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0244 per ML |
|---|---|
| All-time high | $0.0431 (Dec 12, 2018) |
| All-time low | $0.0185 (Nov 20, 2024) |
| 52-week high | $0.0266 |
| 52-week low | $0.0236 |
| Median price | $0.0286 |
| Average price | $0.0301 |
| Largest weekly change | +33.6% (May 18, 2022) |
| Weeks tracked | 411 |
| Tracking since | Aug 15, 2018 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IBUPROFEN 100 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 100 MG/5 ML SUSP, manufactured by Actavis Pharma, Inc., is $0.0244 per ML (NDC 00472200216), effective Jun 24, 2026.
How has the price of IBUPROFEN 100 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 100 MG/5 ML SUSP has declined 33.3%. It has been tracked across 411 weekly CMS publications since Aug 15, 2018.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 100 MG/5 ML SUSP?
Since Aug 15, 2018, the NADAC for IBUPROFEN 100 MG/5 ML SUSP has ranged from a low of $0.0185 (Nov 20, 2024) to a high of $0.0431 (Dec 12, 2018), with a median of $0.0286 per ML.
Are there cheaper alternatives to IBUPROFEN 100 MG/5 ML SUSP?
Yes. 11 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, IBUPROFEN 100 MG/5 ML SUSP, is $0.0239 per ML — about 2% below IBUPROFEN 100 MG/5 ML SUSP.
Who manufactures IBUPROFEN 100 MG/5 ML SUSP?
IBUPROFEN 100 MG/5 ML SUSP (NDC 00472200216) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification